United States Inflammatory Bowel Disease Treatment Market Report 2018

Publisher Name :
Date: 16-Feb-2018
No. of pages: 102
Inquire Before Buying

In this report, the United States Inflammatory Bowel Disease Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Inflammatory Bowel Disease Treatment in these regions, from 2013 to 2025 (forecast).

United States Inflammatory Bowel Disease Treatment market competition by top manufacturers/players, with Inflammatory Bowel Disease Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- AbbVie, Inc.

- Pfizer, Inc.

- Allergan plc.

- Shire Plc

- Novartis AG

- Janssen Biotech, Inc. (Johnson & Johnson)

- UCB Inc.

- Biogen Inc.

- Takeda Pharmaceutical Company Limited.

- Valeant Pharmaceuticals International, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Aminosalicyclates

- TNF Inhibitors

- Corticosteroids

- Immunomodulators

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Retail Pharmacies

- Hospital Pharmacies

- Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Inflammatory Bowel Disease Treatment Market Report 2018

Table of Contents
United States Inflammatory Bowel Disease Treatment Market Report 2018
1 Inflammatory Bowel Disease Treatment Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease Treatment
1.2 Classification of Inflammatory Bowel Disease Treatment by Product Category
1.2.1 United States Inflammatory Bowel Disease Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Inflammatory Bowel Disease Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Aminosalicyclates
1.2.4 TNF Inhibitors
1.2.5 Corticosteroids
1.2.6 Immunomodulators
1.3 United States Inflammatory Bowel Disease Treatment Market by Application/End Users
1.3.1 United States Inflammatory Bowel Disease Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 United States Inflammatory Bowel Disease Treatment Market by Region
1.4.1 United States Inflammatory Bowel Disease Treatment Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Inflammatory Bowel Disease Treatment Status and Prospect (2013-2025)
1.4.3 Southwest Inflammatory Bowel Disease Treatment Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Inflammatory Bowel Disease Treatment Status and Prospect (2013-2025)
1.4.5 New England Inflammatory Bowel Disease Treatment Status and Prospect (2013-2025)
1.4.6 The South Inflammatory Bowel Disease Treatment Status and Prospect (2013-2025)
1.4.7 The Midwest Inflammatory Bowel Disease Treatment Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Inflammatory Bowel Disease Treatment (2013-2025)
1.5.1 United States Inflammatory Bowel Disease Treatment Sales and Growth Rate (2013-2025)
1.5.2 United States Inflammatory Bowel Disease Treatment Revenue and Growth Rate (2013-2025)
2 United States Inflammatory Bowel Disease Treatment Market Competition by Players/Suppliers
2.1 United States Inflammatory Bowel Disease Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Inflammatory Bowel Disease Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Inflammatory Bowel Disease Treatment Average Price by Players/Suppliers (2013-2018)
2.4 United States Inflammatory Bowel Disease Treatment Market Competitive Situation and Trends
2.4.1 United States Inflammatory Bowel Disease Treatment Market Concentration Rate
2.4.2 United States Inflammatory Bowel Disease Treatment Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Inflammatory Bowel Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type
3 United States Inflammatory Bowel Disease Treatment Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Inflammatory Bowel Disease Treatment Sales and Market Share by Region (2013-2018)
3.2 United States Inflammatory Bowel Disease Treatment Revenue and Market Share by Region (2013-2018)
3.3 United States Inflammatory Bowel Disease Treatment Price by Region (2013-2018)
4 United States Inflammatory Bowel Disease Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Inflammatory Bowel Disease Treatment Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Inflammatory Bowel Disease Treatment Revenue and Market Share by Type (2013-2018)
4.3 United States Inflammatory Bowel Disease Treatment Price by Type (2013-2018)
4.4 United States Inflammatory Bowel Disease Treatment Sales Growth Rate by Type (2013-2018)
5 United States Inflammatory Bowel Disease Treatment Sales (Volume) by Application (2013-2018)
5.1 United States Inflammatory Bowel Disease Treatment Sales and Market Share by Application (2013-2018)
5.2 United States Inflammatory Bowel Disease Treatment Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Inflammatory Bowel Disease Treatment Players/Suppliers Profiles and Sales Data
6.1 AbbVie, Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie, Inc. Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Pfizer, Inc.
6.2.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer, Inc. Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Allergan plc.
6.3.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Allergan plc. Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Shire Plc
6.4.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Shire Plc Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Novartis AG
6.5.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis AG Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Janssen Biotech, Inc. (Johnson & Johnson)
6.6.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 UCB Inc.
6.7.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 UCB Inc. Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Biogen Inc.
6.8.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Biogen Inc. Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Takeda Pharmaceutical Company Limited.
6.9.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Valeant Pharmaceuticals International, Inc.
6.10.2 Inflammatory Bowel Disease Treatment Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
7 Inflammatory Bowel Disease Treatment Manufacturing Cost Analysis
7.1 Inflammatory Bowel Disease Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Treatment
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Inflammatory Bowel Disease Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Inflammatory Bowel Disease Treatment Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Inflammatory Bowel Disease Treatment Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Inflammatory Bowel Disease Treatment Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Inflammatory Bowel Disease Treatment Sales Volume Forecast by Type (2018-2025)
11.3 United States Inflammatory Bowel Disease Treatment Sales Volume Forecast by Application (2018-2025)
11.4 United States Inflammatory Bowel Disease Treatment Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Inflammatory Bowel Disease Treatment
Figure United States Inflammatory Bowel Disease Treatment Market Size (K Units) by Type (2013-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Aminosalicyclates Product Picture
Figure TNF Inhibitors Product Picture
Figure Corticosteroids Product Picture
Figure Immunomodulators Product Picture
Figure United States Inflammatory Bowel Disease Treatment Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Inflammatory Bowel Disease Treatment by Application in 2017
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure United States Inflammatory Bowel Disease Treatment Market Size (Million USD) by Region (2013-2025)
Figure The West Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales (K Units) and Growth Rate (2013-2025)
Figure United States Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Inflammatory Bowel Disease Treatment Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Inflammatory Bowel Disease Treatment Sales Share by Players/Suppliers
Figure 2017 United States Inflammatory Bowel Disease Treatment Sales Share by Players/Suppliers
Figure United States Inflammatory Bowel Disease Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Inflammatory Bowel Disease Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Inflammatory Bowel Disease Treatment Revenue Share by Players/Suppliers
Table United States Market Inflammatory Bowel Disease Treatment Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Inflammatory Bowel Disease Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Inflammatory Bowel Disease Treatment Market Share of Top 3 Players/Suppliers
Figure United States Inflammatory Bowel Disease Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Inflammatory Bowel Disease Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Inflammatory Bowel Disease Treatment Product Category
Table United States Inflammatory Bowel Disease Treatment Sales (K Units) by Region (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Sales Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Market Share by Region in 2017
Table United States Inflammatory Bowel Disease Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Revenue Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Revenue Market Share by Region (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Revenue Market Share by Region in 2017
Table United States Inflammatory Bowel Disease Treatment Price (USD/Unit) by Region (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Sales (K Units) by Type (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Sales Share by Type (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Share by Type (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Market Share by Type in 2017
Table United States Inflammatory Bowel Disease Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease Treatment by Type (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease Treatment by Type in 2017
Table United States Inflammatory Bowel Disease Treatment Price (USD/Unit) by Types (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Growth Rate by Type (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Sales (K Units) by Application (2013-2018)
Table United States Inflammatory Bowel Disease Treatment Sales Market Share by Application (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Market Share by Application (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Market Share by Application in 2017
Table United States Inflammatory Bowel Disease Treatment Sales Growth Rate by Application (2013-2018)
Figure United States Inflammatory Bowel Disease Treatment Sales Growth Rate by Application (2013-2018)
Table AbbVie, Inc. Basic Information List
Table AbbVie, Inc. Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie, Inc. Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure AbbVie, Inc. Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure AbbVie, Inc. Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer, Inc. Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Pfizer, Inc. Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Pfizer, Inc. Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Allergan plc. Basic Information List
Table Allergan plc. Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan plc. Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Allergan plc. Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Allergan plc. Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Shire Plc Basic Information List
Table Shire Plc Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire Plc Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Shire Plc Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Shire Plc Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Novartis AG Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Novartis AG Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Janssen Biotech, Inc. (Johnson & Johnson) Basic Information List
Table Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table UCB Inc. Basic Information List
Table UCB Inc. Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure UCB Inc. Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure UCB Inc. Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure UCB Inc. Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Biogen Inc. Basic Information List
Table Biogen Inc. Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Inc. Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Biogen Inc. Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Biogen Inc. Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceutical Company Limited. Basic Information List
Table Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Valeant Pharmaceuticals International, Inc. Basic Information List
Table Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Sales Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Sales Market Share in United States (2013-2018)
Figure Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inflammatory Bowel Disease Treatment
Figure Manufacturing Process Analysis of Inflammatory Bowel Disease Treatment
Figure Inflammatory Bowel Disease Treatment Industrial Chain Analysis
Table Raw Materials Sources of Inflammatory Bowel Disease Treatment Major Players/Suppliers in 2017
Table Major Buyers of Inflammatory Bowel Disease Treatment
Table Distributors/Traders List
Figure United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) Forecast by Type in 2025
Table United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) Forecast by Application in 2025
Table United States Inflammatory Bowel Disease Treatment Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Inflammatory Bowel Disease Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Inflammatory Bowel Disease Treatment Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Levonorgestrel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantab......
  • Global Equine Pharmaceuticals and Supplements Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 158
    Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases. In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Me......
  • Global Cabazitaxel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 132
    Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In......
  • Global Rydapt Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagn......
  • Global Hyperimmune Globulins Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 159
    Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccine......
  • Global Transforming Growth Factor Beta 1 Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Transforming growth factor beta 1 or TGF-ß1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-ß1 is encoded by the TGFB1 gene North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is ......
  • Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week. Traveler's diarrhea is the leading cause of illness among international tra......
  • Global Anticoagulant Drugs Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 31300 million by 2024, from US$ 24600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoag......
  • Global OTC Herbal and Traditional Medicines Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 184
    Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease. Herbal medicine industry is dispersive relatively. Currently, th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs